| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.2 | 2e-05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.21 | 3e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.097 | 0.03 |